SG Americas Securities’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-26,124
| Closed | -$748K | – | 3763 |
|
|
2018
Q4 | $748K | Sell |
26,124
-248,895
| -91% | -$7.07M | 0.01% | 1562 |
|
|
2018
Q3 | $7.67M | Buy |
275,019
+262,151
| +2,037% | +$7.37M | 0.06% | 344 |
|
|
2018
Q2 | $359K | Sell |
12,868
-13,708
| -52% | -$368K | ﹤0.01% | 2237 |
|
|
2018
Q1 | $661K | Buy |
26,576
+16,136
| +155% | +$392K | 0.01% | 1684 |
|
|
2017
Q4 | $253K | Sell |
10,440
-30,059
| -74% | -$792K | ﹤0.01% | 2294 |
|
|
2017
Q3 | $1.12M | Buy |
+40,499
| New | +$1.08M | 0.01% | 1179 |
|
|
2017
Q2 | – | Sell |
-5,200
| Closed | -$140K | – | 3691 |
|
|
2017
Q1 | $140K | Buy |
+5,200
| New | +$144K | ﹤0.01% | 2717 |
|
|
2016
Q4 | – | Sell |
-46,549
| Closed | -$1.16M | – | 3635 |
|
|
2016
Q3 | $1.16M | Buy |
+46,549
| New | +$1.09M | 0.01% | 1059 |
|
|
2015
Q4 | – | Sell |
-10,815
| Closed | -$171K | – | 3117 |
|
|
2015
Q3 | $171K | Buy |
+10,815
| New | +$173K | ﹤0.01% | 1549 |
|
|
2013
Q4 | – | Sell |
-10,744
| Closed | -$141K | – | 3198 |
|
|
2013
Q3 | $141K | Buy |
+10,744
| New | +$141K | ﹤0.01% | 2432 |
|
Other funds holding NXTM
SG Americas Securities's NXTM Position: Q1 2019 in Review
SG Americas Securities sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 26,124 shares — an estimated $748K sold.
SG Americas Securities first reported a position in NXTM in Q3 2013 and held it in 10 quarters. The position peaked at $7.67M in Q3 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- SG Americas Securities reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- SG Americas Securities sold 26,124 NxStage Medical Inc. shares in Q1 2019, an estimated $748K.
- SG Americas Securities first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 10 quarters.
- SG Americas Securities's NxStage Medical Inc. position peaked at $7.67M in Q3 2018.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.